Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
Related Posts
How global freight ships are preparing for Israel-Iran conflict, Strait of Hormuz closure risks
Even if Iran does not close the Strait of Hormuz in response to Israel’s attacks, much of the maritime shipping industry may stay away given […]
‘White gold’ seen as pivotal to Europe’s massive trade deal with South America
Analysts at ING said the significance of critical raw materials like lithium seemed to be “making less headlines” in the coverage of the free trade […]
These midcap utilities are a play on data center demand – and offer generous dividends, Morningstar says
Large cap utilities had a stunning performance in 2024, but investors might consider turning to midcaps if they’re searching for opportunities.